Ba. Harms et al., MANAGEMENT OF FULMINANT ULCERATIVE-COLITIS BY PRIMARY RESTORATIVE PROCTOCOLECTOMY, Diseases of the colon & rectum, 37(10), 1994, pp. 971-978
Severe acute ulcerative colitis unresponsive to medical management is
characterized by multiple associated risk factors including anemia, hy
poproteinemia, and high steroid requirements when urgent surgery is re
quired. Current surgical options include use of primary ileal pouch-an
al anastomosis (IPAA) vs. historic trends favoring colectomy with ileo
stomy. PURPOSE: To evaluate the efficacy of primary IPAA in patients w
ith severe colitis, we reviewed our own experience in 20 patients with
this condition. METHODS: Patients undergoing primary restorative proc
tocolectomy included 13 males and 7 females (mean age, 30.5 +/- 2.4 ye
ars). Exclusion criteria for primary reconstruction included septic pa
tients and patients with associated medical conditions such as pulmona
ry or cardiovascular disease. History of ulcerative colitis averaged 3
.1 +/- 1.1 years (range, 1 month to 19 years). Preoperative mean total
serum protein concentration was 5.0 +/- 0.2 g/dl, and mean albumin co
ncentration was 2.1 +/- 0.2 g/dl, reflecting disease severity. The ave
rage daily steroid requirement at the time of urgent colectomy was 58.
0 +/- 4.4 mg of prednisone (or intravenous equivalent). Primary IPAA i
ncluded 18 ''W'' reservoirs, 1 ''S'' reservoir, and 1 ''J'' reservoir.
RESULTS: Major surgical complications included mild pancreatitis (10
percent), anastomotic leak (5 percent), adrenal insufficiency (15 perc
ent), an upper gastrointestinal bleed (5 percent), and small bowel obs
truction (15 percent). There were no deaths, and no patients developed
pelvic sepsis or required IPAA removal. At three and twelve months, 2
4-hr stool frequency averaged 7.3 +/- 0.4 and 4.9 +/- 0.3, respectivel
y. Overall day and night continence was excellent and not different fr
om patients who underwent elective IPAA procedures for ulcerative coli
tis. CONCLUSIONS: Improved options such as primary IPAA may be safely
used in selected patients requiring urgent surgery for severe or fulmi
nant ulcerative colitis. Medical management should be abbreviated when
disease control cannot be promptly achieved.